相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Hippo pathway in chemotherapeutic drug resistance
Yulei Zhao et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
M. Bartucci et al.
ONCOGENE (2015)
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
Wenjing Zhang et al.
CELL RESEARCH (2014)
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
Xaralabos Varelas
DEVELOPMENT (2014)
The Hippo signaling pathway in stem cell biology and cancer
Jung-Soon Mo et al.
EMBO REPORTS (2014)
Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition
Maren Diepenbruck et al.
JOURNAL OF CELL SCIENCE (2014)
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy Johnson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis
J. Bergholz et al.
ONCOGENE (2014)
ΔNp63α activates CD82 metastasis suppressor to inhibit cancer cell invasion
J. Wu et al.
CELL DEATH & DISEASE (2014)
YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression
Yijun Gao et al.
NATURE COMMUNICATIONS (2014)
The Hippo Transducer TAZ Interacts with the SWI/SNF Complex to Regulate Breast Epithelial Lineage Commitment
Adam Skibinski et al.
CELL REPORTS (2014)
The Hippo effector Yorkie activates transcription by interacting with a histone methyltransferase complex through Ncoa6
Yun Qing et al.
ELIFE (2014)
The role of the Hippo pathway in human disease and tumorigenesis
Daniel A. Barron et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2014)
BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ
Dulcie Lai et al.
CELLULAR SIGNALLING (2013)
The Hippo Effector Yorkie Controls Normal Tissue Growth by Antagonizing Scalloped-Mediated Default Repression
Laura M. Koontz et al.
DEVELOPMENTAL CELL (2013)
Dual role of C/EBPα as an activator and repressor of Gαi2 gene transcription
Jinxian Xu et al.
GENES TO CELLS (2013)
TAZ Expression as a Prognostic Indicator in Colorectal Cancer
Hiu-Fung Yuen et al.
PLOS ONE (2013)
Histone Acetylation-Mediated Regulation of the Hippo Pathway
Dipanjan Basu et al.
PLOS ONE (2013)
Genome-wide Association of Yorkie with Chromatin and Chromatin-Remodeling Complexes
Hyangyee Oh et al.
CELL REPORTS (2013)
Tumour suppressor genes in chemotherapeutic drug response
Dulcie Lai et al.
BIOSCIENCE REPORTS (2012)
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer
Mian Xie et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
TAZ Suppresses NFAT5 Activity through Tyrosine Phosphorylation
Eun Jung Jang et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Protein kinases of the Hippo pathway: Regulation and substrates
Joseph Avruch et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
Wanjin Hong et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation
Huan Liu et al.
PROTEIN & CELL (2012)
Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
Dulcie Lai et al.
CANCER RESEARCH (2011)
SnapShot: The Hippo Signaling Pathway
Caroline Badouel et al.
CELL (2011)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
Molecular mechanism of size control in development and human diseases
Xiaolong Yang et al.
CELL RESEARCH (2011)
Hippo signaling: growth control and beyond
Georg Halder et al.
DEVELOPMENT (2011)
TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma
Tiziana de Cristofaro et al.
EUROPEAN JOURNAL OF CANCER (2011)
Role of ΔNp63γ in Epithelial to Mesenchymal Transition
Jaime Lindsay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line
Zhou Zhou et al.
MOLECULAR MEDICINE REPORTS (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Bin Zhao et al.
NATURE CELL BIOLOGY (2011)
TAZ is a novel oncogene in non-small cell lung cancer
Z. Zhou et al.
ONCOGENE (2011)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein
Bin Zhao et al.
CANCER RESEARCH (2009)
TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation
Tina Di Palma et al.
EXPERIMENTAL CELL RESEARCH (2009)
Mechanisms of transcriptional repression by histone lysine methylation
Philip Hublitz et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2009)
TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation
Siew Wee Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition
Heng Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells
Siew Wee Chan et al.
CANCER RESEARCH (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway
Qun-Ying Lei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Tumor suppressor LATS1 is a negative regulator of oncogene YAP
Yawei Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
p63 and p73 in human cancer: defining the network
M. P. DeYoung et al.
ONCOGENE (2007)
Histone deacetylases-an important class of cellular regulators with a variety of functions
Christian Hildmann et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
Transcriptional activity of Pax3 is co-activated by TAZ
M Murakami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome
M Murakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
TAZ, a transcriptional modulator of mesenchymal stem cell differentiation
JH Hong et al.
SCIENCE (2005)
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
EH Chan et al.
ONCOGENE (2005)
p63 expression in breast cancer - A highly sensitive and specific marker of metoplastic carcinoma
MM Koker et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast - An analysis of 82 samples
JS Reis et al.
CANCER CYTOPATHOLOGY (2003)
CREB-binding protein and p300 in transcriptional regulation
N Vo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
